Tech Company Financing Transactions

Ocera Therapeutics Funding Round

Ocera Therapeutics closed a $20 million funding round on 7/17/2013. Investors included Venrock, Vivo Capital and Deerfield Capital.

Transaction Overview

Company Name
Announced On
7/17/2013
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
525 University Avenue 610
Palo Alto, CA 94301
USA
Email Address
Overview
Ocera Therapeutics Inc. founded in January 2005, is a privately held, clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for gastrointestinal and liver diseases.
Profile
Ocera Therapeutics LinkedIn Company Profile
Social Media
Ocera Therapeutics Company Twitter Account
Company News
Ocera Therapeutics News
Facebook
Ocera Therapeutics on Facebook
YouTube
Ocera Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Linda Grais
  Linda Grais LinkedIn Profile  Linda Grais Twitter Account  Linda Grais News  Linda Grais on Facebook
Chief Financial Officer
Michael Byrnes
  Michael Byrnes LinkedIn Profile  Michael Byrnes Twitter Account  Michael Byrnes News  Michael Byrnes on Facebook
VP - Sales
Gaurav Aggarwal
  Gaurav Aggarwal LinkedIn Profile  Gaurav Aggarwal Twitter Account  Gaurav Aggarwal News  Gaurav Aggarwal on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/16/2013: Ayasdi venture capital transaction
Next: 7/17/2013: Markerly venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary